Drug Shortage Report for DEPAKENE
Report ID | 7165 |
Drug Identification Number | 00443840 |
Brand name | DEPAKENE |
Common or Proper name | Depakene |
Company Name | BGP PHARMA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VALPROIC ACID |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AG |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-01-25 |
Estimated end date | |
Actual end date | 2017-04-24 |
Shortage status | Resolved |
Updated date | 2017-06-08 |
Company comments | This product has been discontinued. A discontinuation report has been created as the product was discontinued on 2017-04-24. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-06-08 | French | Compare |
v5 | 2017-06-08 | English | Compare |
v4 | 2017-05-10 | English | Compare |
v3 | 2017-05-10 | English | Compare |
v2 | 2017-04-18 | French | Compare |
v1 | 2017-04-18 | English | Compare |
Showing 1 to 6 of 6